1. Polymorphisms in the CASPASE genes and survival in patients with early-stage non-small-cell lung cancer.
Yoo SS, Choi JE, Lee WK, Choi YY, Kam S, Kim MJ, Jeon HS, Lee EB, Kim DS, Lee MH, Kim IS, Jheon S, Park JY.
J Clin Oncol. 2009 Dec 1;27(34):5823-9
2. Bacterial pneumonia following cytotoxic chemotherapy for lung cancer: clinical features, treatment outcome and prognostic factors.
Yoo SS, Cha SI, Shin KM, Lee SY, Kim CH, Park JY, Jung TH.
Scand J Infect Dis. 2010 Oct;42(10):734-40.
3. A functional polymorphism in the CHRNA3 gene and risk of chronic obstructive pulmonary disease in a Korean population.
Lee JY, Yoo SS, Kang HG, Jin G, Bae EY, Choi YY, Choi JE, Jeon HS, Lee J, Lee SY, Cha SI, Kim CH, Park JY
J Korean Med Sci 2012;27(12)1536-40.
4. Polymorphisms in DNA repair and apoptosis-related genes and clinical outcomes of patients with non-small cell lung cancer treated with first-line paclitaxel-cisplatin chemotherapy.
Lee SY, Kang HG, Yoo SS, Kang YR, Choi YY, Lee WK, Choi JE, Jeon HS, Shin KM, Oh IJ, Kim KS, Lee J, Cha SI, Kim CH, Kim YC, Park JY.
Lung Cancer. 2013 Nov;82(2):330-9.
5. RET Fusion Genes in Korean Non-Small Cell Lung Cancer.
Yoo SS, Jin G, Jung HJ, Hong MJ, Choi JE, Jeon HS, Lee SY, Lim JO, Park JY.
J Korean Med Sci. 2013 Oct;28(10):1555-8.
6. Replication of results of a genome-wide association study on lung cancer survival in a Korean population.
Yoo SS, Hong MJ, Jeon HS, Lee WK, Lee SY, Lee J, Cha SI, Kim CH, Lee E, Park JY.
Cancer Genet. 2014 Jan-Feb;207(1-2):35-39.
7. Unmethylation of the CHRNB4 gene is an unfavorable prognostic factor in non-small cell lung cancer.
Yoo SS, Lee SM, Do SK, Lee WK, Kim DS, Park JY.
Lung Cancer. 2014 Oct;86(1):85-90.
8. Putative functional variants of XRCC1 identified by RegulomeDB were not associated with lung cancer risk in a Korean population.
Yoo SS, Jin C, Jung DK, Choi YY, Choi JE, Lee WK, Lee SY, Lee J, Cha SI, Kim CH, Seok Y, Lee E, Park JY.
Cancer Genet. 2015 Jan-Feb;208(1-2):19-24.
9. Replication of the results of genome-wide and candidate gene association studies on telomere length in a Korean population.
Do SK, Yoo SS, Choi YY, Choi JE, Jeon HS, Lee WK, Lee SY, Lee J, Cha SI, Kim CH, Park JY.
Korean J Intern Med. 2015 Sep;30(5):719-26.
10. TERT Polymorphism rs2853669 Influences on Lung Cancer Risk in the Korean Population.
Yoo SS, Do SK, Choi JE, Lee SY, Lee J, Cha SI, Kim CH, Park JY.
J Korean Med Sci. 2015 Oct;30(10):1423-8.
11. Genetic Variants in the Wnt Signaling Pathway Are Not Associated with Survival Outcome of Non-Small Cell Lung Cancer in a Korean Population.
Yoo SS, Hong MJ, Choi JE, Lee JH, Baek SA, Lee WK, Lee SY, Lee SY, Lee J, Cha SI, Kim CH, Cho S, Park JY.
J Korean Med Sci. 2016 Mar;31(3):463-6.
12. Effects of polymorphisms identified in genome-wide association studies of never-smoking females on the prognosis of non-small cell lung cancer.
Yoo SS, Kang HG, Choi JE, Do SK, Lee WK, Choi SH, Lee SY, Lee SY, Lee J, Cha SI, Kim CH, Seok Y, Lee E, Kim MS, Lee JM, Cho HJ, Oh IJ, Kim YC, Cho S, Jheon S, Jung CY, Kim MH, Lee MK, Park JY.
Cancer Genet. 2017 Apr;212-213:8-12.
13. Polymorphisms in mitotic checkpoint-related genes can influence survival outcomes of early-stage non-small cell lung cancer.
Kang HG, Yoo SS, Choi JE, Hong MJ, Do SK, Jin CC, Kim S, Lee WK, Choi SH, Lee SY, Kim HJ, Lee SY, Lee J, Cha SI, Kim CH, Seok Y, Lee E, Cho S, Jheon S, Park JY.
Oncotarget. 2017 Jun 27;8(37):61777-61785.
14. Association between polymorphisms in microRNA target sites and survival in early-stage non-small cell lung cancer.
Yoo SS, Hong MJ, Lee JH, Choi JE, Lee SY, Lee J, Cha SI, Kim CH, Seok Y, Lee E, Cho S, Jheon S, Park JY.
Thorac Cancer. 2017 Nov;8(6):682-686.